Comparative analysis and classification of highly divergent mouse rDNA units based on their intergenic spacer (IGS) variability.

Autor: Kim JH; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA., Nagaraja R; National Institute of Aging, Laboratory of Genetics and Genomics, Baltimore, MD, USA., Ogurtsov AY; National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA., Noskov VN; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA., Liskovykh M; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA., Lee HS; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA., Hori Y; The University of Tokyo, Laboratory of Genome Regeneration, Tokyo 113-0032, Japan., Kobayashi T; The University of Tokyo, Laboratory of Genome Regeneration, Tokyo 113-0032, Japan., Hunter K; National Cancer Institute, Laboratory of Cancer Biology and Genetics, Bethesda, MD, USA., Schlessinger D; National Institute of Aging, Laboratory of Genetics and Genomics, Baltimore, MD, USA., Kouprina N; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA., Shabalina SA; National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA., Larionov V; National Cancer Institute, Developmental Therapeutics Branch, Bethesda, MD, USA.

Publikováno v: NAR genomics and bioinformatics [NAR Genom Bioinform] 2024 Jun 14; Vol. 6 (2), pp. lqae070. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).

Transformation-associated recombination (TAR) cloning and its applications for gene function; genome architecture and evolution; biotechnology and biomedicine.

Autor: Kouprina N; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA., Larionov V; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD 20892, USA.

Publikováno v: Oncotarget [Oncotarget] 2023 Dec 22; Vol. 14, pp. 1009-1033. Date of Electronic Publication: 2023 Dec 22.

The genomic structure of a human chromosome 22 nucleolar organizer region determined by TAR cloning.

Autor: Kim JH; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Noskov VN; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Ogurtsov AY; National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, 20892, USA., Nagaraja R; Laboratory of Genetics and Genomics, National Institute on Aging, Baltimore, MD, 21224, USA., Petrov N; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Liskovykh M; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Walenz BP; Computational and Statistical Genomics Branch, National Human Genome Research Institute, Bethesda, MD, 20892, USA., Lee HS; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Kouprina N; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA., Phillippy AM; Computational and Statistical Genomics Branch, National Human Genome Research Institute, Bethesda, MD, 20892, USA., Shabalina SA; National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, 20892, USA. shabalin@ncbi.nlm.nih.gov., Schlessinger D; Laboratory of Genetics and Genomics, National Institute on Aging, Baltimore, MD, 21224, USA. schlessingerd@mail.nih.gov., Larionov V; Developmental Therapeutics Branch, National Cancer Institute, Bethesda, MD, 20892, USA. larionov@mail.nih.gov.

Publikováno v: Scientific reports [Sci Rep] 2021 Feb 04; Vol. 11 (1), pp. 2997. Date of Electronic Publication: 2021 Feb 04.

Novel assay to measure chromosome instability identifies Punica granatum extract that elevates CIN and has a potential for tumor- suppressing therapies.

Autor: Goncharov NV; A.V. Zhirmunsky National Scientific Center of Marine Biology, Russian Academy of Sciences, Vladivostok, Russia.; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia., Kovalskaia VA; Research Centre for Medical Genetics, Moscow, Russia., Romanishin AO; School of Life Sciences, Immanuel Kant Baltic Federal University, Kaliningrad, Russia., Shved NA; A.V. Zhirmunsky National Scientific Center of Marine Biology, Russian Academy of Sciences, Vladivostok, Russia.; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia., Belousov AS; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia., Tiasto VS; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia., Gulaia VS; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia., Neergheen VS; Biopharmaceutical Unit, Centre for Biomedical and Biomaterials Research (CBBR), University of Mauritius, Réduit, Mauritius., Rummun N; Biopharmaceutical Unit, Centre for Biomedical and Biomaterials Research (CBBR), University of Mauritius, Réduit, Mauritius., Liskovykh M; Developmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD, United States., Larionov V; Developmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD, United States., Kouprina N; Developmental Therapeutics Branch, National Cancer Institute, NIH, Bethesda, MD, United States., Kumeiko VV; A.V. Zhirmunsky National Scientific Center of Marine Biology, Russian Academy of Sciences, Vladivostok, Russia.; Institute of Life Sciences and Biomedicine, Far Eastern Federal University, Vladivostok, Russia.

Publikováno v: Frontiers in bioengineering and biotechnology [Front Bioeng Biotechnol] 2022 Dec 19; Vol. 10, pp. 989932. Date of Electronic Publication: 2022 Dec 19 (Print Publication: 2022).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.